Back to search
Resectable Stage II-IIIa Squamous NSCLC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Stage II-IIIa Squamous NSCLC trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Stage II-IIIa Squamous NSCLC trials you may qualify forThis trial is a randomized, controlled, multicenter, open-label study, planning to enroll 116 subjects with resectable stage II-IIIa squamous NSCLC confirmed by…
Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N…
This phase II trial studies how well Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in treating patients with stage I-IIIA non-small…
RATIONALE: Diagnostic procedures, such as positron emission tomography and computed tomography, may help learn the extent of disease and allow doctors to plan 3…